TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scandbio AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2022/04 (consolidated) |
| Turnover |
1,124,617
|
585,963
|
879,903 |
| Financial expenses |
40
|
214
|
1,575 |
| Earnings before taxes |
199,751
|
131,590
|
67,389 |
| EBITDA |
212,552
|
142,636
|
91,063 |
| Total assets |
608,169
|
590,172
|
516,769 |
| Current assets |
424,340
|
426,827
|
349,621 |
| Current liabilities |
297,434
|
190,244
|
161,111 |
| Equity capital |
297,442
|
388,568
|
342,685 |
| - share capital |
6,078
|
5,675
|
5,721 |
| Employees (average) |
103
|
106
|
130 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2022/04 (consolidated) |
| Solvency |
48.9%
|
65.8%
|
66.3% |
| Turnover per employee |
10,919
|
5,528
|
6,768 |
| Profit as a percentage of turnover |
17.8%
|
22.5%
|
7.7% |
| Return on assets (ROA) |
32.9%
|
22.3%
|
13.3% |
| Current ratio |
142.7%
|
224.4%
|
217.0% |
| Return on equity (ROE) |
67.2%
|
33.9%
|
19.7% |
| Change turnover |
497,076
|
-286,908
|
15,692 |
| Change turnover % | 79% | 2% | |
| Chg. No. of employees |
-3
|
-24
|
-9 |
| Chg. No. of employees % | -3% | -6% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2022/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.